Awasty Research Network,LLC

Marion, Ohio 43302

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Diabetes Mellitus, Type 2, Dyslipidemias, High Cardiovascular Risk, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis — Completed
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed